Predicting the Risk for Recurrent Heart Attack(s)

Brief Description

A novel method for identifying patients at increased risk for a second (or subsequent) heart attack.

 

Problem Solved by this Technology

Myocardial infarction (MI), commonly known as a “heart attack,” occurs when blood flow stops to part of the heart, causing damage to the heart muscle. In the developed world, the risk of death is ~10%. Recurrent MI is common after an initial MI, and is associated with increased morbidity and mortality. Traditional methods employed to predict a recurrent MI rely on an analysis of a single risk factor.

 

Applications

Researchers at the University of Rochester have developed a novel multiple risk factor computational algorithm-based method for identifying post-MI individuals that are at a higher risk of a repeat MI. The risk factors comprise levels of certain proteins and other molecules and certain polymorphism in specific genes sequences. This approach presents a more accurate risk calculation that will aid physicians in making better clinical treatment and follow-up decisions.

 

Intellectual Property Status

U.S. patent no. 8,979,753, “Identifying Risk of a Medical Event,” issued 17 March 2015.

 

Technology Status

 UR Ventures is seeking an industrial partner to develop this diagnostic assay into a commercially available product.

 

URV Reference Number: 6-1503

Patent Information:
Title Country Patent No. Issued Date
Identifying Risk of a Medical Event United States 8,979,753 3/17/2015
Category(s):
Diagnostic
For Information, Contact:
Matan Rapoport
Licensing Associate
University of Rochester
585.276.6600
matan.rapoport@rochester.edu
Inventors:
James Corsetti
Charles Sparks
Daniel Ryan
Arthur Moss
Keywords:
Atherosclerosis
Bioassay
Cardiovascular
Database
Diagnostic
Instrument
Medical Device
Software